🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › Nebraska

Etid klinik pou Maladi poumon entèstisyèl nan Nebraska

3 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan Nebraska.

Vil nan Nebraska

Tèks ofisyèl etid la (Anglè)

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Nebraska Medical Center, Omaha
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

  • University of Nebraska Medical Center, Omaha
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06806592

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • CHI Health Creighton University Medical Center - Bergan Mercy, Omaha
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.